What is KeyCorp’s Estimate for RPID FY2024 Earnings?

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) – Research analysts at KeyCorp issued their FY2024 EPS estimates for shares of Rapid Micro Biosystems in a note issued to investors on Tuesday, February 11th. KeyCorp analyst P. Knight anticipates that the company will post earnings per share of ($1.10) for the year. KeyCorp currently has a “Strong-Buy” rating on the stock. The consensus estimate for Rapid Micro Biosystems’ current full-year earnings is ($1.09) per share. KeyCorp also issued estimates for Rapid Micro Biosystems’ Q1 2025 earnings at ($0.27) EPS, Q2 2025 earnings at ($0.25) EPS, Q3 2025 earnings at ($0.24) EPS, Q4 2025 earnings at ($0.23) EPS, FY2025 earnings at ($0.97) EPS and FY2026 earnings at ($0.82) EPS.

Rapid Micro Biosystems Stock Down 2.5 %

Shares of NASDAQ:RPID opened at $3.48 on Friday. The firm has a fifty day moving average of $1.50 and a two-hundred day moving average of $1.13. The firm has a market capitalization of $149.74 million, a P/E ratio of -3.11 and a beta of 1.26. Rapid Micro Biosystems has a 12-month low of $0.58 and a 12-month high of $3.75.

Institutional Investors Weigh In On Rapid Micro Biosystems

A hedge fund recently raised its stake in Rapid Micro Biosystems stock. Renaissance Technologies LLC increased its position in Rapid Micro Biosystems, Inc. (NASDAQ:RPID) by 122.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 183,087 shares of the company’s stock after acquiring an additional 100,942 shares during the quarter. Renaissance Technologies LLC owned about 0.43% of Rapid Micro Biosystems worth $165,000 at the end of the most recent quarter. Institutional investors own 52.60% of the company’s stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.